Concepedia

Matthew D. Gallovic

MD

Statistics

Publications

19

Citations

1K

H-Index

16

Active since

2012

Affiliations

University of North Carolina at Chapel Hill(Current)

The Ohio State University

Naval Medical Research Command

Duke Medical Center

UNC Lineberger Comprehensive Cancer Center

Matthew D. Gallovic is an author at University of North Carolina at Chapel Hill specializing in vaccine delivery, pharmacy, and immunology.

Publications per year

2012–2022

19

Publications

19

A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination

Robert D. Junkins, Matthew D. Gallovic, Brandon M. Johnson et al. · Journal of Controlled Release · 2017 · 151 citations

, , +16

Synthesis and Characterization of Acetalated Dextran Polymer and Microparticles with Ethanol as a Degradation Product

Kevin Kauffman, Clement Do, Sadhana Sharma et al. · ACS Applied Materials & Interfaces · 2012 · 104 citations · Full text

, , +15

Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses

Naihan Chen, Monica M. Johnson, Michael A. Collier et al. · Journal of Controlled Release · 2018 · 90 citations · Full text

, , +17

A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity

Rebekah Watkins-Schulz, Pamela Tiet, Matthew D. Gallovic et al. · Biomaterials · 2019 · 89 citations · Full text

, , +17

Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists

Michael A. Collier, Robert D. Junkins, Matthew D. Gallovic et al. · Molecular Pharmaceutics · 2018 · 81 citations

, , +17

1–5 of 19